
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2019 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 9.195.134 | 716.563 | 1 | ||
| 2020 | 0 | 10.081.334 | 1.700.000 | 1 | ||
| 2019 | 0 | 2.500.000 | 237.500 | 1 | ||
Total number of partners: 19
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 19
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-06-01 | Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC | EPIC-CROWN-2 | participant | 9.195.134 | 5 |
| 2020-01-01 | Personalized immunotherapy in sepsis: a precision medicine based approach | ImmunoSep | participant | 10.081.334 | 15 |
| 2019-10-01 | Trained immunity: improving the next generation of vaccines for the older generation | TRAIN-OLD | participant | 2.500.000 | 2 |